Skip to main content
SpringerLink
Log in
Book cover

Modulation of Presynaptic Calcium Channels

  • Book
  • © 2013

Overview

Editors:
  1. Gary Stephens

    1. , School of Pharmacy, University of Reading, Reading, United Kingdom

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Sumiko Mochida

    1. , Department of Physiology, Tokyo Medical University, Tokyo, Japan

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Written by the world's leading experts
  • A highly important scientific field
  • Clear relevance to current therapeutic drug development

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (15 chapters)

  1. Back Matter

    Pages 363-365
    Download chapter PDF
Back to top

Keywords

About this book

This book will bring together leading international experts to discuss recent advances in basic scientific knowledge regarding the regulation of presynaptic Ca2+ channels. Importantly, Ca2+ channels represent one of the most widely modulated proteins in the body, being the target of a range of effector pathways and drugs; this range will be fully represented here. A number of therapeutic drugs target the Ca2+ channel complex, including the anti-epileptic gabapentinoid and analgesic ziconotide drugs and the pharmaceutical industry is searching for Ca2+ channel blocking drugs, particularly in the pain, epilepsy, ataxia and migraine areas. Such potential future therapies will be discussed here. Scientific disciplines will focus on electrophysiological studies, but will extend to neuroscience, genetics and biochemical areas. The work described will represent advances at the cutting edge of current neuroscience research and is timely and highly appropriate for the Springer book series.

Editors and Affiliations

  • , School of Pharmacy, University of Reading, Reading, United Kingdom

    Gary Stephens

  • , Department of Physiology, Tokyo Medical University, Tokyo, Japan

    Sumiko Mochida

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation